Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
NCT07709741Phase 2Not yet recruiting
- Sponsor
- University of Minnesota
- Start
- Apr 2027
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of carbidopa, levodopa in Parkinson's disease (PD), sponsored by University of Minnesota. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
carbidopalevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07709741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07709741.